Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
Abstract Prolyl‐tRNA synthetase 1 (PARS1) has attracted much interest in controlling pathologic accumulation of collagen containing high amounts of proline in fibrotic diseases. However, there are concerns about its catalytic inhibition for potential adverse effects on global protein synthesis. We d...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Nature
2023-05-01
|
| coleção: | EMBO Molecular Medicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.15252/emmm.202216940 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
